Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD16 antibody

CD16 Reactivity: Human FACS, IP, WB, Func Host: Mouse Monoclonal MEM-154 unconjugated
Catalog No. ABIN126000
  • Target See all CD16 Antibodies
    CD16
    Reactivity
    • 128
    • 20
    • 20
    • 20
    • 16
    • 9
    • 8
    • 8
    • 7
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Human
    Host
    • 111
    • 28
    • 5
    • 1
    Mouse
    Clonality
    • 117
    • 26
    • 1
    Monoclonal
    Conjugate
    • 53
    • 17
    • 12
    • 11
    • 6
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This CD16 antibody is un-conjugated
    Application
    • 115
    • 29
    • 26
    • 25
    • 24
    • 21
    • 21
    • 17
    • 6
    • 5
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    Flow Cytometry (FACS), Immunoprecipitation (IP), Western Blotting (WB), Functional Studies (Func)
    Specificity
    The antibody reacts with the epitope on CD16 antigen that residing in proximity to FG loop (probably BC or C'E loop). CD16 is a low affinity receptor for aggregated IgG (FcgRIII antigen). The antibody reacts with CD16+ granulocytes.
    Purification
    Affinity Chromatography on Protein-A.
    Sterility
    0.2 μm filtered
    Immunogen
    Human granulocytes
    Clone
    MEM-154
    Isotype
    IgG1
    Top Product
    Discover our top product CD16 Primary Antibody
  • Application Notes
    Flow Cytometry: 5-10 mg/mL. Positive control: PBL (peripheral blood lymphocytes). Application note: The antibody MEM-154 does not react with CD16a present on NK cells in many subjects. Immunoprecipitation. Western Blotting (Non-reducing conditions). Functional Application: The antibody MEM-154 blocks binding of human IgG to FcgRIII.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    Azide free PBS, pH ~7.4 preserved by 0.2 μm filter sterilization.
    Preservative
    Azide free
    Storage
    4 °C/-20 °C
    Storage Comment
    Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
    Shelf Life: one year from despatch.
    Expiry Date
    12 months
  • Target
    CD16
    Alternative Name
    CD16 (CD16 Products)
    Synonyms
    Fcgr3 antibody, Fcgr3a antibody, CD16 antibody, FCGR3 antibody, FCGR3@ antibody, CD16b antibody, FCG3 antibody, FCR-10 antibody, FCRIII antibody, FCRIIIb antibody, FcRIII antibody, Fc fragment of IgG, low affinity IIa, receptor antibody, Fc fragment of IgG, low affinity IIIa, receptor (CD16a) antibody, Fc fragment of IgG receptor IIIb antibody, Fc fragment of IgG receptor IIIa antibody, Fc receptor, IgG, low affinity III antibody, Fc-gamma RIII antibody, Fcgr2a antibody, FCGR3A antibody, FCGR3B antibody, Fcgr3 antibody, FCGR3 antibody
    Background
    CD16 (FcgRIII) is a 50-65 kDa glycoprotein serving as a low affinity IgG receptor. Human FcgRIII is expressed in two forms FcgRIII-A and -B. FcgRIII-A is a transmembrane protein of monocytes, macrophages, NK cells and a subset of T cells. It is associated with FceRI-g subunit and is responsible for antibody-dependent NK cell cytotoxicity. Mast cell FcgRIII-A is associated, moreover, with FceRI-b subunit. Besides IgG, FceRI-A can be triggered also by oligomeric IgE. FcgRIII-B is a GPI-linked monomeric receptor expressed on neutrophils and is involved in their activation and induction of a proadhesive phenotype.Synonyms: CD16A, FCG3, FCGR3, FCGR3A, Fc-gamma RIII, Fc-gamma RIII-alpha, Fc-gamma RIIIa, FcR-10, FcRIII, FcRIIIa, IGFR3, IgG Fc receptor III-2, Low affinity immunoglobulin gamma Fc region receptor III-A
    Gene ID
    2214
    UniProt
    P08637
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
You are here:
Support